We studied cytotoxic T lymphocyte (CTL) cross-reactivity between human
immunodeficiency virus type 1 (HIV-1) subtypes within a group of infa
nts infected with either HIV-1 B or non-B clade. Fifteen children were
infected with a clade B virus. Nine were infected with non-B virus, i
ncluding two clade A, four clade D, two clade F, and one clade G. CTL
activities from in vitro activated peripheral blood mononuclear cells
were tested against autologous cell line infected with recombinant vac
cinia viruses encoding for Env, Gag, Pol, or Nef proteins from a clade
A or B isolate. HIV-I-specific CTL elicited from infection with clade
B virus could lyse targets expressing clade A proteins, and vice vers
a. In infants with positive CTL responses, cross-clade recognition was
predominant and was detected within 88% of the Pol, 83% of the Nef, 6
7% of the Gag, and 55% of the Env responders. Longitudinal studies sho
wed that CTL cross-reactivity to both B and A targets was stable for s
everal years. Elicitation of CTL reactivities capable of elimination o
f virus-infected cells is an important goal for the development of an
efficient AIDS vaccine. The significant cross-reactivity of CTL shown
in this study supports the concept that vaccines developed using a sin
gle-clade immunogen may be applicable to induce broadly reactive T cel
l responses. (C) 1998 Academic Press